• Explore /
  • Poster
  • / Liver and/or lung metastasectomy after cetuximab or bevacizumab+FOLFIRI chemotherapy in patients (pts) with metastatic colorectal cancer (mCRC).

Liver and/or lung metastasectomy after cetuximab or bevacizumab+FOLFIRI chemotherapy in patients (pts) with metastatic colorectal cancer (mCRC).

Abstract Poster

Authors

null

Sang-A Kim

Seoul National University Bundang Hospital, Seoul, Korea, Republic of (South)

Sang-A Kim , Ji-Won Kim , Koung Jin Suh , Jin Won Kim , Heung-Kwon Oh , Jai Young Cho , Duck-Woo Kim , Keun-Wook Lee , Sukki Cho , Jee Hyun Kim , Kwhanmien Kim , Sung-Bum Kang , Sanghoon Jheon

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 36, 2018 (suppl 4S; abstr 843)

DOI

10.1200/JCO.2018.36.4_suppl.843

Abstract #

843

Poster Bd #

N19

Abstract Disclosures

Similar Posters

First Author: You Jin Chun

First Author: Wataru Ichikawa

First Author: Emmanuelle Samalin

First Author: Qi Lin